Lattice Biologics Ratios and Metrics

Market cap in millions USD. Fiscal year is October - September.

Millions USD. Fiscal year is Oct - Sep.

Fiscal Year	Current	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	2014 - 2015
Period Ending	Dec '25 Dec 2, 2025	Sep '20 Sep 30, 2020	Sep '19 Sep 30, 2019	Sep '18 Sep 30, 2018	Sep '17 Sep 30, 2017	Sep '16 Sep 30, 2016	2014 - 2015
Market Capitalization	0	5	2	3	8	10	Upgrade
Market Cap Growth	-99.99%	180.45%	-48.14%	-57.78%	-20.07%	-	Upgrade
Enterprise Value	-	8	4	6	10	14	Upgrade
Last Close Price	0.00	0.04	0.02	0.03	0.08	0.15	Upgrade
PS Ratio	0.00	1.93	0.77	2.82	2.82	2.56	Upgrade
PB Ratio	0.00	-0.74	-0.27	-0.61	-1.81	-1.64	Upgrade
P/FCF Ratio	-	-	15.43	97.94	-	-	Upgrade
P/OCF Ratio	-	8.85	10.47	12.35	-	-	Upgrade
EV/Sales Ratio	-	3.14	1.72	5.01	3.73	3.65	Upgrade
EV/FCF Ratio	-	-	34.42	173.82	-	-	Upgrade
Debt / Equity Ratio	-	-0.49	-0.34	-0.38	-0.56	-0.50	Upgrade
Debt / EBITDA Ratio	-	69.62	-	-	-	-	Upgrade
Debt / FCF Ratio	-	-	19.43	60.81	-	-	Upgrade
Asset Turnover	1.01	0.93	0.82	0.36	0.68	0.71	Upgrade
Inventory Turnover	-	2.10	1.09	0.34	1.04	1.12	Upgrade
Quick Ratio	-	0.04	0.04	0.03	0.04	0.06	Upgrade
Current Ratio	-	0.12	0.14	0.24	0.32	0.36	Upgrade
Return on Assets (ROA)	-24.95%	-7.93%	-13.70%	-28.48%	-43.63%	-56.95%	Upgrade
Return on Capital Employed (ROCE)	-611.20%	7.00%	10.80%	38.00%	91.40%	152.50%	Upgrade
Earnings Yield	-743478.91%	-31.25%	-59.82%	-37.74%	-19.74%	-81.25%	Upgrade
FCF Yield	-546717.19%	-1.18%	6.48%	1.02%	-10.03%	-22.57%	Upgrade
Buyback Yield / Dilution	-33.86%	-9.76%	-0.00%	-19.82%	-61.99%	-82.81%	Upgrade

Source: S&P Global Market Intelligence. Standard template. Financial Sources.